Ensuring Medicines and Supplies Reach People
Making health products safe, accessible, and affordableMedicines, vaccines, diagnostics and other health products play a critical role in improving health outcomes and saving lives. Yet unreliable supply chains, frequent stockouts, weak regulation, and high out-of-pocket costs continue to prevent people from accessing essential care. MSH partners with governments, the private sector, faith-based health networks, and local partners to strengthen pharmaceutical and supply chain systems that ensure health products are safe, affordable, quality-assured, and reliably available where they are needed most.
How MSH Helps Expand Access to Lifesaving Medicines and Health Products
MSH helps to optimize end-to-end pharmaceutical and supply chain systems, from forecasting and procurement to distribution, prescribing, and patient use. Our work helps reduce stockouts, improve patient safety, and expand access to essential medicines and vaccines.

Efficient supply chain operations
Through streamlined procurement, optimized transport routes, and real-time logistics data, we help countries increase efficiency of their supply chain operations, realizing savings for both countries and households and reducing stockouts of essential supplies.

Improved patient safety
We help countries strengthen their regulation of pharmaceutical products, reduce falsified and counterfeit products in the marketplace, improve prescribing behavior, and monitor any adverse drug effects to ensure patient safety.

New health product innovations
We support microplanning, logistics, community sensitization, and health worker preparedness to enable countries to introduce new health products, from advances in HIV, tuberculosis, and malaria treatment to vaccines for COVID-19 and human papilloma virus (HPV).

Health emergency and humanitarian response
Amidst disease outbreaks, natural disasters, and conflict, we help countries mobilize resources, partners, and supplies to prepare for and rapidly respond to emergency needs while limiting disruption to maternal, child, and other essential health services during crises.

Private sector engagement
We support governments to engage private sector logistics providers, private pharmacies and clinics, and faith-based health networks to increase communities’ access to safe, quality-assured, effective, and affordable medicines. These private sector and faith-based partners play a key role in delivering lifesaving health products to the last mile, especially in remote and fragile settings.
Results and Highlights

Access increased for maternal and child health products
In the Democratic Republic of Congo, MSH supported registration of 56 quality-assured maternal, newborn, and child health products and strengthened provider access to treatment guidance.

Emergency supply chains mobilize to contain disease outbreaks
MSH has supported COVID-19 vaccine introduction in 17 countries and helped strengthen supply systems during Ebola, Mpox, and other outbreaks or public health emergencies.
In Ethiopia, the Philippines, and Ukraine, MSH-supported private logistics partnerships helped deliver medicines and vaccines to remote and hard-to-reach communities, helping maintain continuity of care during conflict, climate-related disruptions, and other supply chain challenges.

Pharmaceutical systems strengthened to combat antimicrobial resistance
MSH has supported 15 countries to strengthen antimicrobial stewardship, infection prevention, and One Health coordination across human, animal, and environmental health sectors to combat drug-resistant pathogens.
Areas of Expertise
- Supply chain maturity assessment, strategic planning, and transformation
- Pharmaceutical regulation, pharmacovigilance, and patient safety, including the OpenRIMS system
- Health product selection and prioritization
- Market shaping and new product entry
- Forecasting and quantification
- Procurement and financing
- Digitization of logistics management information systems
- Warehousing, distribution, and inventory management, including cold chain
- Pharmaceutical and supply chain workforce capacity
- Standard treatment guidelines and essential medicines lists
- Private sector engagement
- Emergency supply chain logistics
- Last-mile delivery
- Climate-resilient supply chains
- People-centered pharmaceutical services
- Antimicrobial stewardship to combat drug-resistant pathogens
Explore Our Impact

April 9, 2026Story

March 30, 2026Resource
Partner with Us
MSH works alongside governments and partners to strengthen health workforce systems that ensure health workers have the skills, support, and resources they need to deliver high-quality services.







